Regulation of macrophage biology by lithium: A new look at an old drug

Pongali B. Raghavendra, Eunhee Lee, Narayanan Parameswaran

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

Lithium (Li) continues to be a standard small compound used for the treatment of neurological disorders. Besides neuronal cells, Li is also known to affect immune cell function. In spite of its clinical use, potential mechanisms by which Li modulates immune cells, especially macrophages and its clinical relevance in bipolar patients are not well understood. Here, we provide an overview of the literature with regard to Li's effects on monocytes and macrophages. We have also included some of our results showing that Li differentially modulates chemokine gene expression in the absence and presence of Toll-like receptor-4 stimulation in a human macrophage model. Given that Li has a wide range of intracellular targets both in macrophages as well as in other cell types, more studies are needed to further understand the mechanistic basis of Li's effect in neurological and other inflammatory diseases. These studies could undoubtedly identify new therapeutic targets for treating such diseases.

Original languageEnglish
Pages (from-to)277-284
Number of pages8
JournalJournal of NeuroImmune Pharmacology
Volume9
Issue number3
DOIs
Publication statusPublished - 2014

Fingerprint

Lithium
Macrophages
Pharmaceutical Preparations
Toll-Like Receptor 4
Nervous System Diseases
Chemokines
Monocytes
Gene Expression
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Immunology and Allergy
  • Immunology
  • Neuroscience (miscellaneous)
  • Medicine(all)

Cite this

Raghavendra, Pongali B. ; Lee, Eunhee ; Parameswaran, Narayanan. / Regulation of macrophage biology by lithium : A new look at an old drug. In: Journal of NeuroImmune Pharmacology. 2014 ; Vol. 9, No. 3. pp. 277-284.
@article{c54922a50ece43a9a0852cd50027eb12,
title = "Regulation of macrophage biology by lithium: A new look at an old drug",
abstract = "Lithium (Li) continues to be a standard small compound used for the treatment of neurological disorders. Besides neuronal cells, Li is also known to affect immune cell function. In spite of its clinical use, potential mechanisms by which Li modulates immune cells, especially macrophages and its clinical relevance in bipolar patients are not well understood. Here, we provide an overview of the literature with regard to Li's effects on monocytes and macrophages. We have also included some of our results showing that Li differentially modulates chemokine gene expression in the absence and presence of Toll-like receptor-4 stimulation in a human macrophage model. Given that Li has a wide range of intracellular targets both in macrophages as well as in other cell types, more studies are needed to further understand the mechanistic basis of Li's effect in neurological and other inflammatory diseases. These studies could undoubtedly identify new therapeutic targets for treating such diseases.",
author = "Raghavendra, {Pongali B.} and Eunhee Lee and Narayanan Parameswaran",
year = "2014",
doi = "10.1007/s11481-013-9516-y",
language = "English",
volume = "9",
pages = "277--284",
journal = "Journal of NeuroImmune Pharmacology",
issn = "1557-1890",
publisher = "Springer New York",
number = "3",

}

Regulation of macrophage biology by lithium : A new look at an old drug. / Raghavendra, Pongali B.; Lee, Eunhee; Parameswaran, Narayanan.

In: Journal of NeuroImmune Pharmacology, Vol. 9, No. 3, 2014, p. 277-284.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Regulation of macrophage biology by lithium

T2 - A new look at an old drug

AU - Raghavendra, Pongali B.

AU - Lee, Eunhee

AU - Parameswaran, Narayanan

PY - 2014

Y1 - 2014

N2 - Lithium (Li) continues to be a standard small compound used for the treatment of neurological disorders. Besides neuronal cells, Li is also known to affect immune cell function. In spite of its clinical use, potential mechanisms by which Li modulates immune cells, especially macrophages and its clinical relevance in bipolar patients are not well understood. Here, we provide an overview of the literature with regard to Li's effects on monocytes and macrophages. We have also included some of our results showing that Li differentially modulates chemokine gene expression in the absence and presence of Toll-like receptor-4 stimulation in a human macrophage model. Given that Li has a wide range of intracellular targets both in macrophages as well as in other cell types, more studies are needed to further understand the mechanistic basis of Li's effect in neurological and other inflammatory diseases. These studies could undoubtedly identify new therapeutic targets for treating such diseases.

AB - Lithium (Li) continues to be a standard small compound used for the treatment of neurological disorders. Besides neuronal cells, Li is also known to affect immune cell function. In spite of its clinical use, potential mechanisms by which Li modulates immune cells, especially macrophages and its clinical relevance in bipolar patients are not well understood. Here, we provide an overview of the literature with regard to Li's effects on monocytes and macrophages. We have also included some of our results showing that Li differentially modulates chemokine gene expression in the absence and presence of Toll-like receptor-4 stimulation in a human macrophage model. Given that Li has a wide range of intracellular targets both in macrophages as well as in other cell types, more studies are needed to further understand the mechanistic basis of Li's effect in neurological and other inflammatory diseases. These studies could undoubtedly identify new therapeutic targets for treating such diseases.

UR - http://www.scopus.com/inward/record.url?scp=84901248997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901248997&partnerID=8YFLogxK

U2 - 10.1007/s11481-013-9516-y

DO - 10.1007/s11481-013-9516-y

M3 - Review article

C2 - 24277481

AN - SCOPUS:84901248997

VL - 9

SP - 277

EP - 284

JO - Journal of NeuroImmune Pharmacology

JF - Journal of NeuroImmune Pharmacology

SN - 1557-1890

IS - 3

ER -